Literature DB >> 26000108

Adult-onset Still disease: a rare disorder with a potentially fatal outcome.

Roberta Priori1, Serena Colafrancesco1, Angelica Gattamelata1, Manuela Di Franco1, Ugo Di Tondo1, Guido Valesini1.   

Abstract

PURPOSE: The aim of this study was to assess the clinical and laboratory features of a cohort of Italian patients with adult-onset Still disease (AOSD) with particular attention on possible life-threatening complications.
METHODS: The clinical charts of 41 consecutive Italian patients with AOSD referred to our rheumatological department over the last 10 years were retrospectively examined. Data regarding clinical manifestations, laboratory features and complications were collected and compared with those reported in literature.
RESULTS: The most frequent manifestations were: fever (90.2%), arthralgias (80.4%), skin rash (75.6%), sore throat (53.6%), arthritis (51.2%), lymphadenopathy (48.7%), hepatosplenomegaly (41.4%), myalgia (21.9%), fatigue (12%), diarrhoea and vomiting (9.7%), pleural effusion (9.7%), pericardial effusion (4.8%) and abdominal pain (2.4%). In two patients whose cases are described in detail; the course of the disease was complicated by disseminated intravascular coagulopathy, in one patient with a fatal outcome. ESR, CRP and leucocyte count mean values were 69.41 mm/h, 69.05 mg/l and 18,798.5 cell/mm(3) (neutrophils 84.64%), respectively. Serum ferritin levels were increased in 48.7% of patients while transaminases were elevated in 42.6% of patients (71% considering only patients in an active phase of disease).
CONCLUSION: The results of this study are in line with those reported for other cohorts of patients. Even if the prognosis of AOSD is considered favourable, the present study indicates that the disease is a troubling condition needing prompt intervention. Occasionally, AOSD may rapidly worsen with life-threatening events.

Entities:  

Keywords:  Adult-onset Still disease; Auto inflammatory diseases; Disseminated intravascular coagulation; Fever; Myocarditis

Year:  2010        PMID: 26000108      PMCID: PMC4389061          DOI: 10.1007/s13317-010-0009-1

Source DB:  PubMed          Journal:  Auto Immun Highlights        ISSN: 2038-0305


  62 in total

1.  Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.

Authors:  Y Kawaguchi; H Terajima; M Harigai; M Hara; N Kamatani
Journal:  Arthritis Rheum       Date:  2001-07

Review 2.  Adult Still's disease: review of 228 cases from the literature.

Authors:  A Ohta; M Yamaguchi; H Kaneoka; T Nagayoshi; M Hiida
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

3.  Myopericarditis revealing adult-onset Still's disease.

Authors:  F Vandergheynst; J Gosset; P van de Borne; G Decaux
Journal:  Acta Clin Belg       Date:  2005 Sep-Oct       Impact factor: 1.264

4.  Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease.

Authors:  S S Uppal; I R Pande; A Kumar; S Kailash; N G Sekharan; C M Adya; A N Malaviya
Journal:  Br J Rheumatol       Date:  1995-05

5.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

6.  Adult onset Still's disease as a cause of acute liver failure.

Authors:  Molly M Thabah; Kirti K Singh; Sethu M Madhavan; Rajiva Gupta
Journal:  Trop Gastroenterol       Date:  2008 Jan-Mar

Review 7.  [A case of adult onset Still's disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation].

Authors:  M Yokoyama; A Suwa; T Shinozawa; T Fujii; T Mimori; M Akizuki; Y Ichikawa; T Tojo
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  1995-04

8.  Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G.

Authors:  J R Diamond
Journal:  J Nephrol       Date:  1997 Sep-Oct       Impact factor: 3.902

9.  Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients.

Authors:  Guihua Zhu; Gang Liu; Yixin Liu; Qibing Xie; Guixiu Shi
Journal:  J Clin Rheumatol       Date:  2009-09       Impact factor: 3.517

10.  Multi-organ failure in adult onset Still's disease: a septic disguise.

Authors:  Paul R J Ames; Emily Walker; Darren Aw; David Marshall; Francois de Villiers; Manfred Staber
Journal:  Clin Rheumatol       Date:  2008-10-07       Impact factor: 2.980

View more
  4 in total

1.  IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease Activity.

Authors:  Serena Colafrancesco; Roberta Priori; Cristiano Alessandri; Carlo Perricone; Monica Pendolino; Giovanna Picarelli; Guido Valesini
Journal:  Int J Inflam       Date:  2012-06-18

2.  Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still's disease: a case report.

Authors:  Seong Joon Ahn; Sun Jin Hwang; Byung Ro Lee
Journal:  BMC Ophthalmol       Date:  2016-11-08       Impact factor: 2.209

3.  Bibliometrics analysis on the research status and trends of adult-onset Still's disease: 1921-2021.

Authors:  Aining Qin; Jing Sun; Chao Gao; Chunying Li
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

4.  Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Authors:  Jurgen Sota; Donato Rigante; Piero Ruscitti; Antonella Insalaco; Paolo Sfriso; Salvatore de Vita; Rolando Cimaz; Giuseppe Lopalco; Giacomo Emmi; Francesco La Torre; Claudia Fabiani; Alma Nunzia Olivieri; Marco Cattalini; Daniele Cammelli; Romina Gallizzi; Maria Alessio; Raffaele Manna; Ombretta Viapiana; Micol Frassi; Manuela Pardeo; Armin Maier; Carlo Salvarani; Rosaria Talarico; Marta Mosca; Serena Colafrancesco; Roberta Priori; Maria Cristina Maggio; Carla Gaggiano; Salvatore Grosso; Fabrizio De Benedetti; Antonio Vitale; Roberto Giacomelli; Luca Cantarini
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.